Sarah C Gilbert
Sarah C Gilbert
Professor of Vaccinology, Jenner Institute, Oxford University
Verified email at ndm.ox.ac.uk
Title
Cited by
Cited by
Year
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10269), 99-111, 2021
13812021
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ...
The Lancet 396 (10249), 467-478, 2020
11262020
Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara
J Schneider, SC Gilbert, TJ Blanchard, T Hanke, KJ Robson, CM Hannan, ...
Nature medicine 4 (4), 397-402, 1998
8231998
Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans
H McShane, AA Pathan, CR Sander, SM Keating, SC Gilbert, K Huygen, ...
Nature medicine 10 (11), 1240-1244, 2004
7302004
Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans
SJ McConkey, WHH Reece, VS Moorthy, D Webster, S Dunachie, ...
Nature medicine 9 (6), 729-735, 2003
6932003
Natural selection of hemi-and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria
C Ruwende, SC Khoo, RW Snow, SNR Yates, D Kwiatkowski, S Gupta, ...
Nature 376 (6537), 246-249, 1995
6871995
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
N van Doremalen, T Lambe, A Spencer, S Belij-Rammerstorfer, ...
Nature 586 (7830), 578-582, 2020
5512020
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
MN Ramasamy, AM Minassian, KJ Ewer, AL Flaxman, PM Folegatti, ...
The Lancet 396 (10267), 1979-1993, 2020
4492020
Upregulation of TGF-β, FOXP3, and CD4+ CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection
M Walther, JE Tongren, L Andrews, D Korbel, E King, H Fletcher, ...
Immunity 23 (3), 287-296, 2005
4432005
Association of malaria parasite population structure, HLA, and immunological antagonism
SC Gilbert, M Plebanski, S Gupta, J Morris, M Cox, M Aidoo, ...
Science 279 (5354), 1173-1177, 1998
3131998
Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara
DP Webster, S Dunachie, JM Vuola, T Berthoud, S Keating, SM Laidlaw, ...
Proceedings of the National Academy of Sciences 102 (13), 4836-4841, 2005
3122005
Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime
T Hanke, TJ Blanchard, J Schneider, CM Hannan, M Becker, SC Gilbert, ...
Vaccine 16 (5), 439-445, 1998
3081998
Enhanced Immunogenicity of CD4+ T-Cell Responses and Protective Efficacy of a DNA-Modified Vaccinia Virus Ankara Prime-Boost Vaccination Regimen for …
H McShane, R Brookes, SC Gilbert, AVS Hill
Infection and immunity 69 (2), 681-686, 2001
3072001
Potent CD8+ T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA−NP+M1
TK Berthoud, M Hamill, PJ Lillie, L Hwenda, KA Collins, KJ Ewer, A Milicic, ...
Clinical infectious diseases 52 (1), 1-7, 2011
3042011
Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation
KJ Ewer, GA O’Hara, CJA Duncan, KA Collins, SH Sheehy, ...
Nature communications 4 (1), 1-10, 2013
2882013
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four …
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10277), 881-891, 2021
2862021
Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B. 1.351 variant
SA Madhi, V Baillie, CL Cutland, M Voysey, AL Koen, L Fairlie, ...
New England Journal of Medicine 384 (20), 1885-1898, 2021
2842021
Viral Booster Vaccines Improve Mycobacterium bovis BCG-Induced Protection against Bovine Tuberculosis
HM Vordermeier, B Villarreal-Ramos, PJ Cockle, M McAulay, SG Rhodes, ...
Infection and immunity 77 (8), 3364-3373, 2009
2732009
Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria
NW Schmidt, RL Podyminogin, NS Butler, VP Badovinac, BJ Tucker, ...
Proceedings of the National Academy of Sciences 105 (37), 14017-14022, 2008
2642008
Induction of CD8+ T cells using heterologous prime‐boost immunisation strategies
J Schneider, SC Gilbert, CM Hannan, P Dégano, E Prieur, EG Sheu, ...
Immunological reviews 170 (1), 29-38, 1999
2501999
The system can't perform the operation now. Try again later.
Articles 1–20